Nanobodies Market to Grow with a CAGR of 18.23% through 2029
Rising demand
for targeted therapeutics is expected to drive the Global Nanobodies Market
growth in the forecast period, 2025-2029.
According to
TechSci Research report, “Nanobodies Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2029”, the Global Nanobodies
Market stood at USD 489.21 Million in 2023 and is anticipated to grow with a
CAGR of 18.23% in the forecast period, 2025-2029. The rising prevalence of
dental disorders, coupled with advancements in dental technology and
techniques, has led to an increased number of dental procedures being performed
globally. From routine check-ups and preventive care to complex restorative and
cosmetic procedures, dental practices are witnessing a surge in patient visits
and treatment volumes. This surge in dental procedures translates into a higher
demand for disposable dental products used during various stages of treatment,
including examination, diagnosis, and treatment delivery. Consequently, the
growing number of dental procedures acts as a key driver fueling the growth of
the Nanobodies market.
Individuals are
increasingly recognizing the significance of oral health and hygiene. Efforts
led by governments, dental associations, and oral health advocates have been
instrumental in educating the public about the importance of regular dental
check-ups, maintaining proper oral hygiene, and preventive measures. This
increased awareness has led to a surge in demand for dental services and
products, particularly disposable dental items that promote hygienic treatment
environments. As a result, the global Nanobodies market is experiencing
significant growth driven by this heightened awareness of oral health and
hygiene.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Nanobodies Market”
The Global Nanobodies
market is segmented into
type, end
user, application, regional distribution, and company.
Based on the
type, In 2023, the mono-specific segment emerged as the dominant force in the global Nanobodies market. Multi-specific nanobodies have showcased remarkable adaptability, extending beyond therapeutic applications into diagnostics and research domains. In diagnostics, these nanobodies enable the simultaneous detection of multiple disease biomarkers, enhancing diagnostic accuracy and efficacy. In the research realm, they streamline the investigation of complex biological processes and protein-protein interactions, providing valuable insights into disease mechanisms and potential therapeutic targets. Advancements in biotechnology and protein engineering have driven the development and refinement of innovative platforms for producing and improving multi-specific nanobodies, thereby enhancing their market reach and growth. Collaborative efforts between industry players and academic researchers have further accelerated the expansion of the multi-specific sector, with significant investments in research and development expediting the transition of multi-specific nanobodies from laboratory experimentation to clinical application.
Based
on the application, In 2023, the oncology segment emerged as the primary driver of growth in the global Nanobodies market. The oncology field has attracted substantial investment in research and development, particularly focusing on identifying new targets and developing personalized treatment strategies. Collaborations between industry leaders and academic institutions have accelerated the progress of nanobody-based oncology treatments, moving from preclinical studies to clinical trials and eventual commercialization. Oncology remains a significant area of unmet medical need, with the incidence of various cancers rising worldwide. Nanobodies offer distinct advantages in cancer therapy, including precise targeting, improved tissue penetration, and reduced off-target effects, making them promising candidates for precision medicine initiatives. They can be customized to specifically target tumor-associated antigens or pathways, facilitating the development of highly targeted and effective cancer therapies.
Based
on the End User, pharmaceutical and biotechnology companies segment emerged as
the dominant segment in the global Nanobodies market in 2023. Pharmaceutical and biotechnology
companies play a pivotal role in the research, development, and
commercialization of nanobody-based therapeutics and diagnostics. These
companies possess the resources, expertise, and infrastructure required for
conducting large-scale research programs, preclinical studies, and clinical
trials aimed at validating the efficacy and safety of nanobody candidates
across various disease indications.
The
pharmaceutical and biotechnology industry has been actively investing in
nanobody research and development, recognizing the potential of nanobodies as a
versatile platform for drug discovery and development. With a focus on
addressing unmet medical needs and expanding their product pipelines,
pharmaceutical and biotechnology companies have been incorporating nanobodies
into their research programs and partnering with academic institutions and
biotech firms to access novel nanobody technologies and candidates.
North
America possesses a strong and well-established biotechnology and
pharmaceutical sector, characterized by a notable presence of prominent
companies and research organizations specializing in antibody-based
therapeutics. North America emerged as the dominant region in the Global
Nanobodies Market in 2023, holding the largest market share. North America
benefits from a well-established healthcare infrastructure and advanced
research ecosystem, comprising academic institutions, research laboratories,
and medical centers at the forefront of nanobody research. Collaborative
efforts between academia and industry drive innovation and accelerate the pace
of nanobody development, positioning North America as a global leader in
nanobody research and commercialization.
Major companies
operating in Global Nanobodies Market are:
- Hybrigenics
Services
- Novo Nordisk A/S
- Merck KGaA
- Bristol Myers
Squibb Company
- Boehringer
Ingelheim International GmbH
- Sanofi S.A
- Beroni Group
- Shenzhen Kangti
Co., Ltd.
- GlaxoSmithKline plc
- Sensei
Biotherapeutics, Inc
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The global Nanobodies
market is poised for significant expansion in the coming years. With the
increasing emphasis on infection control and patient safety amidst the ongoing
COVID-19 pandemic, the Global Nanobodies Market is expected to witness
significant growth in the forecast period. Dental practices worldwide are
prioritizing stringent hygiene protocols, driving the demand for disposable
dental products to minimize the risk of cross-contamination. Additionally, the
adoption of advanced dental technologies and procedures is fueling the need for
specialized disposable items tailored to these innovations. said Mr. Karan
Chechi, Research Director with TechSci Research, a research-based management
consulting firm.
“Nanobodies
Market - Global Industry Size, Share, Trends, Opportunity and Forecast, By Type
(Mono-Specific, Multi-Specific) By Application (Acquired Thrombotic
Thrombocytopenic Purpura (TTP), Respiratory Syncytial Virus Infection,
Rheumatoid Arthritis, Systemic Lupus Erythematosus, Oncology, Psoriasis,
Chronic Kidney Diseases, Bone Disorders, Others) By End User (Pharmaceutical
& Biotechnology Companies, Research Laboratories, and Others), By Region,
By Competition, 2019-2029F”, has evaluated the future growth potential of Global
Nanobodies Market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Nanobodies Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com